Picture for Vladimir Aladinskiy

Vladimir Aladinskiy

AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor

Add code
Jan 21, 2022
Figure 1 for AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor
Figure 2 for AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor
Figure 3 for AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor
Figure 4 for AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor
Viaarxiv icon

Chemistry42: An AI-based platform for de novo molecular design

Add code
Jan 22, 2021
Figure 1 for Chemistry42: An AI-based platform for de novo molecular design
Figure 2 for Chemistry42: An AI-based platform for de novo molecular design
Figure 3 for Chemistry42: An AI-based platform for de novo molecular design
Viaarxiv icon

Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models

Add code
Nov 29, 2018
Figure 1 for Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Figure 2 for Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Figure 3 for Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Figure 4 for Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Viaarxiv icon